English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2

Lehmann, K., Seemann, P., Stricker, S., Sammar, M., Meyer, B., Suering, K., et al. (2003). Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proceedings of the National Academy of Sciences of the United States of America, 100(21), 12277-12282. doi:10.1073/pnas.2133476100.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Proc. Natl. Acad. Sci. U. S. A.

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Lehmann, Katarina, Author
Seemann, Petra1, Author           
Stricker, Sigmar1, Author           
Sammar, Marai, Author
Meyer, Birgit, Author
Suering, Katrin2, Author
Majewski, Frank, Author
Tinschert, Sigrid1, Author           
Grzeschik, Karl-Heinz H., Author
Mueller, Dietmar, Author
Knaus, Petra, Author
Nurnberg, Peter, Author
Mundlos, Stefan1, Author           
Affiliations:
1Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433557              
2Max Planck Society, ou_persistent13              

Content

show
hide
Free keywords: -
 Abstract: Brachydactyly (BD) type A2 is an autosomal dominant hand malformation characterized by shortening and lateral deviation of the index fingers and, to a variable degree, shortening and deviation of the first and second toes. We performed linkage analysis in two unrelated German families and mapped a locus for BD type A2 to 4q21-q25. This interval includes the gene bone morphogenetic protein receptor 1B (BMPR1B), a type I transmembrane serinethreonine kinase. In one family, we identified a T599 A mutation changing an isoleucine into a lysine residue (I200K) within the glycine/serine (GS) domain of BMPR1B, a region involved in phosphorylation of the receptor. In the other family we identified a C1456 T mutation leading to an arginine-to-tryptophan amino acid change (R486W) in a highly conserved region C-terminal of the BMPR1B kinase domain. An in vitro kinase assay showed that the I200K mutation is kinase-deficient, whereas the R486W mutation has normal kinase activity, indicating a different pathogenic mechanism. Functional analyses with a micromass culture system revealed a strong inhibition of chondrogenesis by both mutant receptors. Overexpression of mutant chBmpR1b in vivo in chick embryos by using a retroviral system resulted either in a BD phenotype with shortening and/or missing phalanges similar to the human phenotype or in severe hypoplasia of the entire limb. These findings imply that both mutations identified in human BMPR1B affect cartilage formation in a dominant-negative manner.

Details

show
hide
Language(s): eng - English
 Dates: 2003-10-14
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 174918
ISI: 000186024300063
DOI: 10.1073/pnas.2133476100
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Proceedings of the National Academy of Sciences of the United States of America
  Alternative Title : Proc. Natl. Acad. Sci. U. S. A.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 100 (21) Sequence Number: - Start / End Page: 12277 - 12282 Identifier: ISSN: 0027-8424